| Date Filed | Type | Description |
| 12/23/2019 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 175,000 options to buy
@ $0.36, valued at
$63k
|
|
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,654 shares
@ $0
Granted 5,000 options to buy
@ $56.5, valued at
$282.5k
|
|
| 01/03/2019 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 335,000 options to buy
@ $0.83, valued at
$278.1k
|
|
| 09/20/2018 |
4/A
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 10,000 shares
@ $2.6339, valued at
$26.3k
|
|
| 09/20/2018 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 10,000 shares
@ $2.6339, valued at
$26.3k
|
|
| 06/15/2018 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 3,050 shares
@ $0
Granted 5,000 options to buy
@ $49.17, valued at
$245.9k
|
|
| 12/08/2017 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 107,995 options to buy
@ $1.91, valued at
$206.3k
|
|
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2016 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC. |
| 06/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2016 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC. |
| 06/16/2015 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 40,145 shares
@ $0 |
|
| 04/01/2015 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Sold 76,268 shares
@ $4.4875, valued at
$342.3k
Exercised 40,268 options to buy
@ $1.49, valued at
$60k
Exercised 36,000 options to buy
@ $1.27, valued at
$45.7k
Sold 76,268 shares
@ $4.4875, valued at
$342.3k
Exercised 40,268 options to buy
@ $1.49, valued at
$60k
Exercised 36,000 options to buy
@ $1.27, valued at
$45.7k
|
|
| 02/06/2015 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 109,491 options to buy
@ $0.4589, valued at
$50.2k
|
|
| 11/17/2014 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 3,000 shares
@ $2.43, valued at
$7.3k
|
|
| 07/10/2014 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 1,000 shares
@ $2.65, valued at
$2.7k
|
|
| 07/09/2014 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 1,000 shares
@ $2.6629, valued at
$2.7k
|
|
| 06/16/2014 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 25,384 shares
@ $0 |
|
| 10/29/2013 |
4
| WOODS RANDALL E (President & Chief Exec Officer) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Granted 430,375 options to buy
@ $4.41, valued at
$1.9M
|
|
| 08/22/2013 |
4
| WOODS RANDALL E (President & CEO) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 2,500 shares
@ $4.495, valued at
$11.2k
|
|
| 08/20/2013 |
4
| WOODS RANDALL E (President & CEO) has filed a Form 4 on SOPHIRIS BIO INC.|
Txns:
| Bought 10,000 shares
@ $4.2871, valued at
$42.9k
|
|
| 06/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/14/2009 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC |
| 03/18/2009 |
4
| WOODS RANDALL E (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC |